Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > BioTuesdays Feature Article on Spectral

<< Previous

Bullboard Posts

Next >>

Comment by SimonSaidon Nov 15, 2024 6:54pm

117 Views

Post# 36315931

RE:RE:RE:RE:RE:BioTuesdays Feature Article on Spectral

I am new to Spectral and am trying to get an understanding as to the value. Have been adding to my position over the past months and will continue. That said, the Carlye Group, through its purchase of Vantive, now hold the Exclusive Disitribution Agreement...correct? Does that guarantee a purchase of Spectral? Or, could the Carlye Group elect to continue paying Spectral based on the Distribution Agreement once approved by the FDA? Doesn't make sense to me to proceed that way; however, it is a possibility?

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale